IL15RA drives antagonistic mechanisms of cancer development and immune control in lymphocyte-enriched triple-negative breast cancers. (2014)

First Author: Marra P

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-14-0637

PubMed Identifier: 24980552

Publication URI: http://europepmc.org/abstract/MED/24980552

Type: Journal Article/Review

Volume: 74

Parent Publication: Cancer research

Issue: 17

ISSN: 0008-5472